Bio-Techne Corporation
TECH · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $8 | $11 | $13 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $8 | $12 | $13 | $14 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 5.2% | 2% | 2.8% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 64.8% | 66.4% | 67.7% | 68.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.8% | 27% | 40.2% | 37.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 6% | 14.5% | 25.1% | 24.6% |
| EPS Diluted | 0.46 | 1.05 | 1.76 | 1.66 |
| % Growth | -56.2% | -40.3% | 6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |